Skip to main content

Ron Hahn, Lars Holmkvist, and Robert Millman

Premium

Genospectra has appointed Ron Hahn to its board, the Fremont, Calif.-based company said last week. Hahn, a venture capitalist focusing on health care and life sciences, is a partner of Battelle Ventures, which led Genospectra’s recent financing round.


Applied Biosystems has named Lars Holmkvist as president of the company’s European region. Holmkvist will manage approximately 1,000 employees in that region, and will report to Catherine Burzik, AB’s president, the company said.

Holmkvist most recently served as vice president of vascular and cardiac surgery in Western Europe for Medtronic. He has also been vice president, vascular for Europe, the Middle East, and Africa for Boston Scientific, and held executive positions with Pharmacia Hospital Care and Becton Dickinson.


Robert Millman has been appointed chief patent counsel of Alnylam Pharmaceuticals, the Cambridge, Mass.-based company said last week. He has been a company consultant since 2003. Most recently, Millman was a freelance intellectual property consultant for biotechnology companies and the interim chief patent counsel at Infinity Pharmaceuticals. Prior to that, he was chief IP counsel at Celera Genomics. Millman holds a JD degree from the Washington College of Law at American University. He also holds an MS in genetics from Washington State University and a BS in biochemistry from the University of California, Riverside.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.